David A. Siegel Caribou Biosciences, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 1,470,700 shares of CRBU stock, worth $1.93 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,470,700
Previous 1,054,100
39.52%
Holding current value
$1.93 Million
Previous $2.06 Million
13.77%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CRBU
# of Institutions
138Shares Held
54.4MCall Options Held
21.2KPut Options Held
96.4K-
Black Rock Inc. New York, NY6.95MShares$9.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.57MShares$5.98 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.88MShares$5.08 Million0.4% of portfolio
-
Morgan Stanley New York, NY2.75MShares$3.6 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.5MShares$3.27 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $79.7M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...